Adverse reactions are listed by system organ class and the following frequencies: Very common (1/10); Common (1/100 to <1/10); Uncommon (1/1,000 to <1/100); Rare (1/10,000 to <1/1,000); Very rare (<1/10,000); Not known (cannot be estimated from the available data). (See table.)
Click on icon to see table/diagram/image
There was no significant effect on the prostate specific antigen (PSA) levels for up to 24 months reported after treatment with terazosin.